Gline Matthew sold ROIV
March 31, 2026 · Form 4 insider transaction
Gline Matthew sold 304,684 shares of Roivant Sciences Ltd. at $27.70 per share, a transaction worth $8.44M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
304,684
Price
$27.70
Total value
$8.44M
InsiderGline Matthew
RoleOfficer, Director
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 31, 2026
Filing dateApril 1, 2026
Shares owned after17,025,890
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.